Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Medicare Rx Bill Would Attract 90% Of Beneficiaries, Staffer Says

Executive Summary

House Republicans are confident that their Medicare prescription drug benefit proposal will attract at least 90% of the eligible population, Ways & Means/Health Subcommittee Staff Director John McManus said

You may also be interested in...



House Medicare Rx Bill Offers Juicier Reinsurance Bait; HIAA Bites

The House Republican Medicare drug benefit bill is wooing plan sponsors with a 35% direct subsidy plus a 30% reinsurance rate for additional costs

House Medicare Rx Bill Offers Juicier Reinsurance Bait; HIAA Bites

The House Republican Medicare drug benefit bill is wooing plan sponsors with a 35% direct subsidy plus a 30% reinsurance rate for additional costs

Medicare Rx Price Controls Inevitable If PBMs Do Not Bear Risk – CMS’ Scully

A Medicare prescription drug plan that does not require PBMs to bear risk for the cost of drugs would inevitably result in federal price controls, Centers for Medicare & Medicaid Services Administrator Tom Scully said

Related Content

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel